Roble Belko & Company’s Abbott ABT Stock Holding History

Roble Belko & Company’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64K	Hold	700	–	–	0.01%	198
2026 Q1	$72K	Buy	700 +151	+28%	+$17.1K	0.01%	184
2025 Q4	$69K	Hold	549	–	–	0.01%	185
2025 Q3	$74K	Buy	549 +49	+10%	+$6.43K	0.01%	156
2025 Q2	$68K	Sell	500 -29	-5%	-$3.82K	0.01%	160
2025 Q1	$70K	Buy	529 +29	+6%	+$3.69K	0.01%	155
2024 Q4	$57K	Buy	+500	New	+$57.8K	0.01%	164
2023 Q3	–	Sell	-4	Closed	–	–	285
2023 Q2	$0	Sell	4 -34	-89%	-$3.62K	﹤0.01%	287
2023 Q1	$4K	Hold	38	–	–	﹤0.01%	249
2022 Q4	$4K	Hold	38	–	–	﹤0.01%	275
2022 Q3	$4K	Hold	38	–	–	﹤0.01%	270
2022 Q2	$4K	Sell	38 -146	-79%	-$16.6K	﹤0.01%	268
2022 Q1	$22K	Buy	184 +150	+441%	+$18.6K	﹤0.01%	228
2021 Q4	$5K	Hold	34	–	–	﹤0.01%	283
2021 Q3	$4K	Hold	34	–	–	﹤0.01%	268
2021 Q2	$4K	Hold	34	–	–	﹤0.01%	287
2021 Q1	$4K	Hold	34	–	–	﹤0.01%	276
2020 Q4	$4K	Hold	34	–	–	﹤0.01%	264
2020 Q3	$4K	Buy	+34	New	+$3.45K	﹤0.01%	263
2017 Q3	–	Sell	-40	Closed	-$2K	–	289
2017 Q2	$2K	Buy	+40	New	+$1.81K	﹤0.01%	258
2016 Q4	–	Sell	-1,949	Closed	-$82K	–	367
2016 Q3	$82K	Buy	1,949 +149	+8%	+$6.38K	0.04%	88
2016 Q2	$71K	Buy	+1,800	New	+$71.6K	0.04%	92

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Roble Belko & Company's ABT Position: Q2 2026 in Review

Roble Belko & Company held its Abbott (ABT) position steady in Q2 2026 at 700 shares worth $64K. The position accounts for 0.01% of the portfolio, ranked #198.

Roble Belko & Company first reported a position in ABT in Q2 2016 and has held it in 22 quarters since. The position peaked at $82K in Q3 2016. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Roble Belko & Company held 700 shares of Abbott worth $64K as of Q2 2026.
Roble Belko & Company left its Abbott share count unchanged in Q2 2026.
Abbott made up 0.01% of Roble Belko & Company's portfolio in Q2 2026, its #198 holding.
Roble Belko & Company first reported a position in Abbott in Q2 2016 and has held it in 22 quarters since.
Roble Belko & Company's Abbott position peaked at $82K in Q3 2016.
2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.